Pneumococcal infections, caused by the bacterium Streptococcus pneumoniae, remain a significant global public health concern. This Gram-positive bacterium is a leading cause of respiratory tract infections, including pneumonia, otitis media, and sinusitis. Pneumococcal infections can also lead to invasive diseases such as bacteremia and meningitis, particularly in vulnerable populations such as young children, the elderly, and individuals with weakened immune systems. Transmission of S. pneumoniae occurs through respiratory droplets, and colonization in the nasopharynx is common, especially in children. The bacterium possesses various virulence factors, including a polysaccharide capsule that aids in evading the host immune system. When infection occurs, the clinical presentation can vary widely, ranging from mild upper respiratory symptoms to severe pneumonia or life-threatening invasive diseases. Preventive measures for pneumococcal infections include vaccination, with pneumococcal conjugate vaccines (PCVs) and pneumococcal polysaccharide vaccines (PPVs) targeting different age groups. Vaccination has led to a significant reduction in the incidence of pneumococcal diseases, highlighting the importance of immunization in public health efforts.
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : From bench to preclinical evaluation: LL-37-derived peptides for combating orthopedic infections
Vincenzo Pennone, IRCCS Galeazzi Sant’Ambrogio Hospital, Italy
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Personalized and precision medicine (PPM) as a unique healthcare model to se-cure the human healthcare, wellness and biosafety through the view of public health, network driven healthcare services and lifestyle management
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation